Navigation Links
Anthera Pharmaceuticals Reports 2013 Third Quarter Financial Results, Clinical and Regulatory Update
Date:10/29/2013

D, to the US FDA for the investigation of blisibimod in IgA nephropathy incorporating feedback from both the initial meetings with the US FDA and PMDA.  As part of this submission the Company will provide a second clinical study protocol, BRILLIANT-SC, intended to evaluate the use of blisibimod as a treatment for proteinuria in patients with IgA nephropathy. 

About Anthera PharmaceuticalsAnthera Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing products to treat serious diseases associated with autoimmune disorders including lupus, glomerulonephritis and IgA nephropathy.

Safe Harbor Statement

Any statements contained in this press release that refer to future events or other non-historical matters, including statements that are preceded by, followed by, or that include such words as "estimate," "intend," "anticipate," "believe," "plan," "goal," "expect," "project," or similar statements, are forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based on Anthera's expectations as of the date of this press release and are subject to certain risks and uncertainties that could cause actual results to differ materially as set forth in Anthera's public filings with the SEC, including Anthera's Annual Report on Form 10-K for the year ended December 31, 2012 and Quarterly Reports on Form 10-Q for the quarters ended March 31 and June 30, 2013.  Anthera disclaims any intent or obligation to update any forward-looking statements, whether because of new information, future events or otherwise, except as required by applicable law.

CONTACT: Dennis Lutz of Anthera Pharmaceuticals, Inc., dlutz@anthera.com or 510.856.5598. ANTHERA PHARMACEUTICALS, INC.(A Development Stage Company)CONSOLIDATED STATEMENTS
'/>"/>

SOURCE Anthera Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Anthera Pharmaceuticals Announces Emerging Data from Phase 2 Open-Label Extension Study to be Presented at the ACR/ARHP 2013 Annual Scientific Meeting
2. Anthera Pharmaceuticals Reports 2013 Second Quarter Financial Results
3. Anthera Announces Initiation of BRIGHT-SC Phase 2 Clinical Study in IgA Nephropathy with Blisibimod
4. Anthera Pharmaceuticals Announces Receipt of Nasdaq Notice
5. Anthera Pharmaceuticals Announces Personnel Changes
6. Anthera Pharmaceuticals to Present at Annual Jefferies Healthcare Conference
7. Anthera Pharmaceuticals Reports 2013 First Quarter Financial Results
8. Anthera Pharmaceuticals Announces Additional Data from Phase 2b PEARL-SC Blisibimod Study
9. Anthera Refinances Existing Debt with New $20 Million Credit Facility and Secures $18.5 Million Committed Equity Financing Facility
10. Anthera Initiates CHABLIS-SC1 Phase 3 Clinical Study in Lupus with Blisibimod
11. Anthera Announces Data from the Phase 2b PEARL-SC Study Will Be Presented at the 10th International Congress on Systemic Lupus Erythematosus
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... PARIS and MOUNTAIN VIEW, Calif. ... (NYSE: SNY ; EURONEXT: SAN) and the life ... collaborating to improve care and outcomes for people with ... leadership in diabetes treatments and devices with Google,s expertise ... The companies will explore how to improve diabetes care ...
(Date:8/31/2015)... , Aug. 31, 2015  Asterias Biotherapeutics, Inc. ... the emerging field of regenerative medicine, today announced ... Chicago -based Rush University Medical ... activity of escalating doses of AST-OPC1 (oligodendrocyte progenitor ... motor complete cervical spinal cord injury (SCI). This ...
(Date:8/31/2015)...   BioLife Solutions , Inc. (NASDAQ: ... of proprietary clinical grade cell and tissue ... media and a related cloud hosted biologistics ... shippers ("BioLife" or the "Company"), today announced ... company focused on developing and commercializing novel therapeutics ...
Breaking Medicine Technology:Sanofi to Collaborate with Google Life Sciences to Improve Diabetes Health Outcomes 2Sanofi to Collaborate with Google Life Sciences to Improve Diabetes Health Outcomes 3Sanofi to Collaborate with Google Life Sciences to Improve Diabetes Health Outcomes 4Sanofi to Collaborate with Google Life Sciences to Improve Diabetes Health Outcomes 5Sanofi to Collaborate with Google Life Sciences to Improve Diabetes Health Outcomes 6Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 2Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 3Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 4Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 5Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 6BioLife Solutions Customer TiGenix Phase 3 Clinical Trial Meets Primary Endpoint 2BioLife Solutions Customer TiGenix Phase 3 Clinical Trial Meets Primary Endpoint 3BioLife Solutions Customer TiGenix Phase 3 Clinical Trial Meets Primary Endpoint 4BioLife Solutions Customer TiGenix Phase 3 Clinical Trial Meets Primary Endpoint 5
(Date:8/31/2015)... ... August 31, 2015 , ... Since 1946, the doctors ... care. From the moment a patient arrives at the office, the staff will ... work with each and every patient to create a complete dental treatment plan that ...
(Date:8/31/2015)... ... , ... Dr. Paul Kovatis of Orthopedic Spine & Sports Medicine Center is ... all surgical and non-surgical disorders of the leg, ankle and foot. He also ... spine. , Dr. Paul Kovatis completed his orthopedic leg, ankle and foot fellowship training ...
(Date:8/31/2015)... Nashville, TN (PRWEB) , ... August 31, 2015 , ... ... and how it may be prevented during Amblyopia Awareness Month. Only a comprehensive eye ... is the most common cause of visual impairment among children, affecting approximately 2 to ...
(Date:8/31/2015)... ... 2015 , ... According to an article published August 3rd on ... who underwent bariatric surgery “felt significantly better two years after surgery.” The article goes ... the study felt that their “mental health had been normalized” at the point when ...
(Date:8/31/2015)... ... August 31, 2015 , ... Nine innovative healthcare companies ... Innovations in Healthcare(SM) Awards Event , on October 21, 2015, in Long Beach. ... innovative organizations and individuals who are dramatically reducing the cost of quality healthcare. ...
Breaking Medicine News(10 mins):Health News:NJ Top Dentists Presents, Clifton Dental Associates! 2Health News:NJ Top Docs Presents, Dr. Paul Kovatis of Orthopedic Spine & Sports Medicine Center on his Five Year Anniversary as an "NJ Top Doc" 2Health News:Renowned Eye Surgeon Dr. Stewart Shofner Shares Information about the Causes of Lazy Eye During Amblyopia Awareness Month 2Health News:Renowned Eye Surgeon Dr. Stewart Shofner Shares Information about the Causes of Lazy Eye During Amblyopia Awareness Month 3Health News:Article on Adolescent Bariatric Surgery Demonstrates the Powerful Effect of Being in Control, Notes Dr. Michael Feiz 2Health News:Article on Adolescent Bariatric Surgery Demonstrates the Powerful Effect of Being in Control, Notes Dr. Michael Feiz 3Health News:9 Finalists Named for Innovations in Healthcare(SM) ABBY Awards; Winners to be Chosen October 21 in Long Beach, CA 2Health News:9 Finalists Named for Innovations in Healthcare(SM) ABBY Awards; Winners to be Chosen October 21 in Long Beach, CA 3Health News:9 Finalists Named for Innovations in Healthcare(SM) ABBY Awards; Winners to be Chosen October 21 in Long Beach, CA 4Health News:9 Finalists Named for Innovations in Healthcare(SM) ABBY Awards; Winners to be Chosen October 21 in Long Beach, CA 5Health News:9 Finalists Named for Innovations in Healthcare(SM) ABBY Awards; Winners to be Chosen October 21 in Long Beach, CA 6Health News:9 Finalists Named for Innovations in Healthcare(SM) ABBY Awards; Winners to be Chosen October 21 in Long Beach, CA 7Health News:9 Finalists Named for Innovations in Healthcare(SM) ABBY Awards; Winners to be Chosen October 21 in Long Beach, CA 8
... Approximately 100 student,government leaders, representing more than ... Nashville Oct. 5-7 to discuss,healthcare issues under the ... engage young Americans in the debate over healthcare., ... Center, just blocks from,the Oct. 7 presidential debate ...
... CALDWELL, N.J., Sept. 17 Community,Education Centers, Inc. ... Department of Postsecondary Education held a dedication,ceremony for ... John J. Clancy, Chairman and CEO of CEC ... and Chancellor Bradley,Byrne, as well as over two ...
... Parents Dental Tips for Back-to-School, ROANOKE, Va., Sept. ... for parents to take a refresher course in their ... the U.S. Department of Health and,Human Services, students miss ... dental problems or related conditions. Dental pain can distract,your ...
... of Medicine have modified a honeybee venom toxin so that ... inner workings of ion channels that control heart rate and ... selectively allow the passage of small ions such as sodium, ... The study, published in the Proceedings of the National ...
... Fallon has presented Curemark,s most recent findings on autism at the ... 24-29 at Magdalene College in Oxford. , ... Rye, ... announced today that Founder and CEO Dr. Joan Fallon has presented ...
... American Kidney Fund today issued an urgent appeal for contributions for disaster ... , ... Rockville, MD (PRWEB) September 17, 2008 -- The American Kidney ... help dialysis patients who have been affected by Hurricane Ike. , , ...
Cached Medicine News:Health News:College Students Seek Healthcare Solutions on Eve of Debate 2Health News:Prisoner Reentry Facility Holds Dedication Ceremony 2Health News:Smart Minds Start With Healthy Mouths 2Health News:Smart Minds Start With Healthy Mouths 3Health News:Penn researchers use honeybee venom toxin to develop a new tool for studying hypertension 2Health News:Curemark CEO Presents Autism Findings at Prestigious Neurobiology Conference at Oxford 2Health News:American Kidney Fund Issues Appeal for Disaster Relief Contributions 2Health News:American Kidney Fund Issues Appeal for Disaster Relief Contributions 3
... VACUETTE® erythrocyte sedimentation rate analysers, which ... new generation unites the well-established advantages ... range of additional innovations which guarantee ... sedimentation rate. Cost effectiveness is an ...
Blood sedimentation rate analysis...
Blood sedimentation rate analysis...
The Sedimat 15 Automated sedrate system provides an accurate ESR result in only 15 minutes. Fast, in-office results (before patient leaves the office) can lead to improved patient therapy....
Medicine Products: